Home
APRE
APRE News

Latest Aprea Therapeutics Inc. Common stock (APRE) News on July 27, 2024

Will Aprea Therapeutics (NASDAQ:APRE) Spend Its Cash Wisely?

Simply Wall St.

5 days ago

Will Aprea Therapeutics (NASDAQ:APRE) Spend Its Cash Wisely?

Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor, on Monday, June 24, 2024

GlobeNewswire

a month ago

Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor, on Monday, June 24, 2024

Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051

GlobeNewswire

a month ago

Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051

Pleasing Signs As A Number Of Insiders Buy Aprea Therapeutics Stock

Simply Wall St.

2 months ago

Pleasing Signs As A Number Of Insiders Buy Aprea Therapeutics Stock

Aprea Therapeutics Announces that Safety Review Committee (SRC) Endorses Dosing of Patients with ATRN-119 at 800 mg Once Daily in Ongoing ABOYA-119 Clinical Trial

GlobeNewswire

2 months ago

Aprea Therapeutics Announces that Safety Review Committee (SRC) Endorses Dosing of Patients with ATRN-119 at 800 mg Once Daily in Ongoing ABOYA-119 Clinical Trial

Aprea Therapeutics Reports First quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire

2 months ago

Aprea Therapeutics Reports First quarter 2024 Financial Results and Provides a Business Update

Aprea Therapeutics to Attend the 2024 RBC Capital Markets Global Healthcare Conference

GlobeNewswire

2 months ago

Aprea Therapeutics to Attend the 2024 RBC Capital Markets Global Healthcare Conference

Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer and Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024

GlobeNewswire

4 months ago

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

GlobeNewswire

4 months ago

Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update

Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million

GlobeNewswire

5 months ago

Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million

Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its Next Generation WEE1 Kinase Inhibitor for Cyclin E Overexpressing Cancers

GlobeNewswire

5 months ago

Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its Next Generation WEE1 Kinase Inhibitor for Cyclin E Overexpressing Cancers

Aprea Therapeutics Announces Acceptance of Abstracts at American Association of Cancer Research Annual Meeting 2024

GlobeNewswire

5 months ago

Aprea Therapeutics Announces Acceptance of Abstracts at American Association of Cancer Research Annual Meeting 2024

Aprea Therapeutics Announces Submission of IND Application for APR-1051, a Next Generation WEE1 Kinase Inhibitor

GlobeNewswire

6 months ago

Aprea Therapeutics Announces Submission of IND Application for APR-1051, a Next Generation WEE1 Kinase Inhibitor

Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria

GlobeNewswire

6 months ago

Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria

Aprea Therapeutics to Present at DDR Inhibitors Summit 2024

GlobeNewswire

6 months ago

Aprea Therapeutics to Present at DDR Inhibitors Summit 2024

Aware Adds Product Strategy Innovator to Executive Team to Further Align Biometric Platform and Vision with Market Growth

GlobeNewswire

6 months ago

Aware Adds Product Strategy Innovator to Executive Team to Further Align Biometric Platform and Vision with Market Growth

Bitcoin Depot Places Order for 500 New BTM Kiosks from Kiosk Provider Genmega

GlobeNewswire

6 months ago

Bitcoin Depot Places Order for 500 New BTM Kiosks from Kiosk Provider Genmega

Adlucent achieves Google Cloud Partner status, strengthening client solutions

GlobeNewswire

6 months ago

Adlucent achieves Google Cloud Partner status, strengthening client solutions

VCI Global Announces Pricing of $2.75 Million Public Offering

GlobeNewswire

6 months ago

VCI Global Announces Pricing of $2.75 Million Public Offering

Will Aprea Therapeutics (NASDAQ:APRE) Spend Its Cash Wisely?

Simply Wall St.

7 months ago

Will Aprea Therapeutics (NASDAQ:APRE) Spend Its Cash Wisely?

OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Both Sign and Symptom Endpoints in its First-in-Human Phase 2 Trial of OK-101 in Patients with Dry Eye Disease

GlobeNewswire

7 months ago

OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Both Sign and Symptom Endpoints in its First-in-Human Phase 2 Trial of OK-101 in Patients with Dry Eye Disease

17EdTech Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

GlobeNewswire

7 months ago

17EdTech Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024

GlobeNewswire

7 months ago

Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024

Bullish Aspira Women's Health Insiders Loaded Up On US$702.9k Of Stock

Simply Wall St.

7 months ago

Bullish Aspira Women's Health Insiders Loaded Up On US$702.9k Of Stock

Canadian Investment Regulatory Organization Trading Halt - DGHI

CNW Group

7 months ago

Canadian Investment Regulatory Organization Trading Halt - DGHI

3 Tech Stocks Under $10 to Boost Your Portfolio in 2024

Zacks

7 months ago

3 Tech Stocks Under $10 to Boost Your Portfolio in 2024

Know Labs Expands Medical and Scientific Advisory Board

Business Wire

7 months ago

Know Labs Expands Medical and Scientific Advisory Board

Perma-Pipe International Holdings (NASDAQ:PPIH) Is Experiencing Growth In Returns On Capital

Simply Wall St.

7 months ago

Perma-Pipe International Holdings (NASDAQ:PPIH) Is Experiencing Growth In Returns On Capital

180 Degree Capital Corp. Notes Appointment of Kevin M. Rendino to the Board of Directors of Its Portfolio Company, Synchronoss Technologies, Inc.

GlobeNewswire

8 months ago

180 Degree Capital Corp. Notes Appointment of Kevin M. Rendino to the Board of Directors of Its Portfolio Company, Synchronoss Technologies, Inc.

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

GlobeNewswire

8 months ago

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

The Joint Corp. to Participate in the 12th Annual Roth Deer Valley Conference

GlobeNewswire

8 months ago

The Joint Corp. to Participate in the 12th Annual Roth Deer Valley Conference

Is It Too Late To Consider Buying DarioHealth Corp. (NASDAQ:DRIO)?

Simply Wall St.

8 months ago

Is It Too Late To Consider Buying DarioHealth Corp. (NASDAQ:DRIO)?

Tortoise Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of November 30, 2023, for TYG, NTG, TTP, NDP and TPZ

ACCESSWIRE

8 months ago

Tortoise Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of November 30, 2023, for TYG, NTG, TTP, NDP and TPZ

MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer

GlobeNewswire

8 months ago

MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer

Plutonian Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination

PR Newswire

8 months ago

Plutonian Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination

Associated Press Finance

8 months ago

Cross Timbers: Q3 Earnings Snapshot

Li-Cycle Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

8 months ago

Li-Cycle Reports Third Quarter 2023 Financial Results and Provides Business Update

Toro Third Quarter 2023 Earnings: EPS: US$1.79 (vs US$1.92 in 3Q 2022)

Simply Wall St.

9 months ago

Toro Third Quarter 2023 Earnings: EPS: US$1.79 (vs US$1.92 in 3Q 2022)

Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

GlobeNewswire

9 months ago

Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

MEDIROM Healthcare Technologies (NASDAQ:MRM) Might Be Having Difficulty Using Its Capital Effectively

Simply Wall St.

9 months ago

MEDIROM Healthcare Technologies (NASDAQ:MRM) Might Be Having Difficulty Using Its Capital Effectively

Landmark Bancorp (NASDAQ:LARK) Will Pay A Dividend Of $0.21

Simply Wall St.

9 months ago

Landmark Bancorp (NASDAQ:LARK) Will Pay A Dividend Of $0.21

Share on Social Networks: